Dr Geoffrey Heber, the founder of Ultraceuticals, has built up a formidable reputation for being ahead of his time.
Efficacy has always been at the forefront of one of Australia’s leading cosmeceutical brands, which has been providing solutions for major skincare concerns such as anti-ageing, acne and hyper-pigmentation since 1998.
Ultraceuticals is sold through hundreds of clinics nationwide and David Jones and its use of high levels of active ingredients such as Vitamins A and C and AHAs and cutting-edge delivery systems offer the most effective skincare products without the need for a dermatologist’s prescription.
The US, the world’s largest single beauty market, has been a key target for Ultraceuticals for some time, as the brand has expanded overseas in countries like Russia and New Zealand.
The company had planned to roll out in the US in early 2020, but the move was postponed because of the Covid-19 pandemic.
Ultraceuticals has signed three US distributors with four more to come on board by mid-year. According to a report in WWD, aka the “bible of fashion”, Ultraceuticals is looking to be available in about 150 locations across the US by the end of the year and through its own dedicated website.
The brand has also been growing strongly in Australia over the past five years. Ultraceuticals ticks all the major boxes with Australian women looking for advanced skincare – cruelty-free, proven benefits and Australian-made.
The company’s RVR90 program – an acronym for real visible results – has been central to Ultraceuticals on-going success. Following a professional consultation, clients are asked to commit to a regimen for 90 days to transform their skin through a personalised treatment strategy for a range of concerns from congested skin to a reduction in lines and wrinkles.